Wikidata

(Q77800427)

English

Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555)

scientific article published on 01 May 1999

In more languages

Statements

title
Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10344749
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10344749%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q77800427&oldid=1856244832"